| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8312825 | Clinica Chimica Acta | 2013 | 7 Pages |
Abstract
Elecsys anti-HCV II shortens the seroconversion window. It is suitable for screening HCV infection in clinical samples, including those from immunocompromised patients, due to the excellent sensitivity and specificity. Further investigation of the subtype inclusivity in a larger sample number might be warranted.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ruifeng Yang, Wenli Guan, Qian Wang, Yan Liu, Lai Wei,